home / stock / syggf / syggf quote
Last: | $0.0558 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.0558 |
High: | $0 |
Low: | $0 |
Volume: | 80 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0558 | $0 | $0.0558 | $0 | $0 | 80 | 04-23-2024 |
$0.0558 | $0.0558 | $0.0558 | $0.0558 | $0.0558 | 1,000 | 04-19-2024 |
$0.0505 | $0.07425 | $0.0505 | $0.07425 | $0.0505 | 5,000 | 04-11-2024 |
$0.06 | $0.045 | $0.06 | $0.06 | $0.045 | 50,002 | 03-29-2024 |
$0.06 | $0.045 | $0.06 | $0.06 | $0.045 | 50,002 | 03-28-2024 |
$0.061 | $0.061 | $0.061 | $0.061 | $0.061 | 3,500 | 03-27-2024 |
$0.0654 | $0.0654 | $0.0654 | $0.0654 | $0.0654 | 301 | 03-26-2024 |
$0.0566 | $0.0566 | $0.0566 | $0.0566 | $0.0566 | 1,000 | 03-25-2024 |
$0.0623 | $0 | $0.0623 | $0 | $0 | 50 | 03-14-2024 |
$0.0623 | $0.0623 | $0.0623 | $0.0623 | $0.0623 | 6,100 | 03-13-2024 |
$0.0689 | $0.0689 | $0.0689 | $0.0689 | $0.0689 | 4,445 | 03-11-2024 |
$0.045 | $0.045 | $0.045 | $0.045 | $0.045 | 2,500 | 03-08-2024 |
$0.045 | $0.045 | $0.045 | $0.045 | $0.045 | 6,489 | 03-06-2024 |
$0.04526 | $0.04526 | $0.04526 | $0.04526 | $0.04526 | 300 | 03-05-2024 |
$0.045 | $0.045 | $0.045 | $0.045 | $0.045 | 400 | 03-04-2024 |
$0.045 | $0.045 | $0.045 | $0.045 | $0.045 | 200 | 02-29-2024 |
$0.045 | $0.045 | $0.045 | $0.045 | $0.045 | 2,000 | 02-23-2024 |
$0.063 | $0.063 | $0.063 | $0.063 | $0.063 | 335 | 02-22-2024 |
$0.058 | $0.058 | $0.058 | $0.058 | $0.058 | 2,000 | 02-21-2024 |
$0.045 | $0.073 | $0.045 | $0.073 | $0.045 | 12,500 | 02-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
Synairgen PLC Ord Company Name:
SYGGF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden speaks to Thomas Warner from Proactive London about the company's ongoing efforts to develop what he describes as a "drug to help patients handle respiratory viruses." He explains that work on the drug lon...
(NewsDirect) Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden talks to Proactive following the release of full year results for calendar year 2022 - a year he says was "quite challenging at times." Marsden discusses the UK-based respiratory company's clinical development...